MARKET

TELO

TELO

Telomir Pharms
NASDAQ
1.235
-0.035
-2.76%
Opening 11:36 05/15 EDT
OPEN
1.270
PREV CLOSE
1.270
HIGH
1.270
LOW
1.230
VOLUME
18.52K
TURNOVER
--
52 WEEK HIGH
3.100
52 WEEK LOW
1.050
MARKET CAP
42.46M
P/E (TTM)
-3.7538
1D
5D
1M
3M
1Y
5Y
1D
Telomir net loss narrows to $990,947 in Q1 2026
PUBT · 1d ago
Weekly Report: what happened at TELO last week (0504-0508)?
Weekly Report · 4d ago
Weekly Report: what happened at TELO last week (0427-0501)?
Weekly Report · 05/04 09:14
Telomir announces U.S. FDA cleared IND application for Telomir-Zn
TipRanks · 04/30 15:55
Telomir Pharmaceuticals Receives FDA IND Clearance for Telomir-Zn
TipRanks · 04/30 13:44
TELOMIR PHARMACEUTICALS INC - PLANS TO INITIATE PHASE 1/2 TRIAL FOR TELOMIR-ZN IN 1H 2026 - SEC FILING
Reuters · 04/30 12:21
Telomir Pharmaceuticals wins FDA IND clearance for Telomir-Zn in triple-negative breast cancer
PUBT · 04/30 12:02
EXCLUSIVE: Telomir Pharmaceuticals Secures FDA Nod For Its Breast Cancer Therapy To Advance Into Human Study
Benzinga · 04/30 11:46
More
About TELO
Telomir Pharmaceuticals, Inc. is a biotechnology company developing small-molecule therapeutics designed to target epigenetic and metabolic mechanisms implicated in cancer, aging, and degenerative disease. The Company's lead candidate, Telomir-1 (Telomir-Zn), is an investigational therapy that has demonstrated activity in preclinical studies involving modulation of intracellular metal homeostasis, epigenetic regulation, mitochondrial function, and genomic stability. Telomir-1 is an oral small molecule metal ion regulator designed to extend telomere caps, maintain cellular balance, and combat oxidative stress, a key driver of aging and disease progression. By modulating essential metal ions such as iron, and copper, Telomir-1 may help protect against age related conditions, including Progeria (a rare genetic disorder that causes rapid aging in children), Wilson’s disease, and Age-related Macular Degeneration (AMD), as well as Type 2 diabetes, breast cancer, and Alzheimer’s disease.

Webull offers Telomir Pharmaceuticals Inc stock information, including NASDAQ: TELO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TELO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TELO stock methods without spending real money on the virtual paper trading platform.